Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer 17 April
PEPFAR and The Global Fund Make Additional Investment in Gilead's Lenacapavir for HIV Prevention to Further Expand Access 14 April
Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline 07 April
